Good Clinical Practice Guidance and Pragmatic Clinical Trials
Open Access
- 1 March 2016
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 133 (9), 872-880
- https://doi.org/10.1161/circulationaha.115.019902
Abstract
Randomized, clinical trials are commonly regarded as the highest level of evidence to support clinical decisions. Good Clinical Practice guidelines have been constructed to provide an ethical and scientific quality standard for trials that involve human subjects in a manner aligned with the Declaration of Helsinki. Originally designed to provide a unified standard of trial data to support submission to regulatory authorities, the principles may also be applied to other studies of human subjects. Although the application of Good Clinical Practice principles generally led to improvements in the quality and consistency of trial operations, these principles have also contributed to increasing trial complexity and costs. Alternatively, the growing availability of electronic health record data has facilitated the possibility for streamlined pragmatic clinical trials. The central tenets of Good Clinical Practice and pragmatic clinical trials represent potential tensions in trial design (stringent quality and highly efficient operations). In the present article, we highlight potential areas of discordance between Good Clinical Practice guidelines and the principles of pragmatic clinical trials and suggest strategies to streamline study conduct in an ethical manner to optimally perform clinical trials in the electronic age.Keywords
This publication has 56 references indexed in Scilit:
- Are Routinely Collected NHS Administrative Records Suitable for Endpoint Identification in Clinical Trials? Evidence from the West of Scotland Coronary Prevention StudyPLOS ONE, 2013
- Randomized Clinical Trials — Removing Unnecessary ObstaclesNew England Journal of Medicine, 2013
- Embedding a randomized clinical trial into an ongoing registry infrastructure: Unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women)American Heart Journal, 2013
- Treatment with Adenosine Diphosphate Receptor Inhibitors—Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational researchAmerican Heart Journal, 2011
- Variability in Protocol Design Complexity by Phase and Therapeutic AreaDrug Information Journal, 2011
- The Unintended Consequences of Clinical Trials RegulationsPLoS Medicine, 2009
- Ethical and Scientific Implications of the Globalization of Clinical ResearchNew England Journal of Medicine, 2009
- Postmarket evaluation of breakthrough technologiesAmerican Heart Journal, 2008
- Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post–myocardial infarction secondary preventive therapiesAmerican Heart Journal, 2008
- Good Clinical Practice and the Conduct of Clinical Studies in Pediatric OncologyPediatric Clinics of North America, 2008